Description
Recombinant monoclonal antibody to Amyloid Beta. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 21F12.
Target
Amyloid Beta
Target Alias Names
Abeta, A-beta, Aβ, Aβ42, Alzheimer disease amyloid protein, S-APP-beta
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression